K2 Principal Fund is in the back door.
The K2 Principal Fund L.P. acquires common shares of NeuroMedix Inc.
TORONTO, Apr 24, 2007 (Canada NewsWire via COMTEX News Network) --
The K2 Principal Fund L.P. ("K2") announced that it has acquired 1,725,000 common shares of NeuroMedix Inc. ("NeuroMedix"). As a result of the acquisition of such shares, K2 owns 1,725,000 common shares representing approximately 10.83% of the issued and outstanding common shares of NeuroMedix.
The common shares were purchased by K2 on the TSX Venture Exchange. K2 acquired the securities for investment purposes only and may, depending on market and other conditions, increase or decrease its beneficial ownership, control or direction over, or exercise its current rights to acquire, common shares or other securities of NeuroMedix through market transactions, private agreements or otherwise.
SOURCE: K2 Principal Fund L.P.
Dan Gosselin, The K2 Principal Fund L.P., (416) 365-2155
Copyright (C) 2007 CNW Group. All rights reserved.